There is emerging evidence for the novel biomarkers galactomannan and tumor necrosis factor receptor 2 (TNF-R2) for monitoring non-invasive fungal lung disease in CF and asthma (Baxter et al., 2013a; Ghebre et al., 2017). The gene discussed is TNFRSF1B; the disease is asthma.